DULAGLUTIDE

DULAGLUTIDE was reported 89369 times

DULAGLUTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTRIC HYPOMOTILITY 87 0.2834
1 GASTROINTESTINAL HYPOMOTILITY 553 0.2451
2 ACCIDENTAL UNDERDOSE 2370 0.1645
3 IMPAIRED GASTRIC EMPTYING 2003 0.1468
4 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 161 0.1344
5 GLYCOSYLATED HAEMOGLOBIN INCREASED 2979 0.1179
6 INJECTION SITE COLDNESS 67 0.0790
7 EXTRA DOSE ADMINISTERED 3202 0.0790
8 GLYCOSYLATED HAEMOGLOBIN DECREASED 124 0.0770
9 INJECTION SITE INJURY 363 0.0654
10 MEDULLARY THYROID CANCER 21 0.0618
11 ERUCTATION 1107 0.0572
12 BLOOD GLUCOSE ABNORMAL 1035 0.0560
13 BLOOD GLUCOSE INCREASED 9960 0.0528
14 ACCIDENTAL OVERDOSE 1897 0.0518
15 THIRST DECREASED 32 0.0510
16 DIABETIC METABOLIC DECOMPENSATION 67 0.0482
17 GENITAL ABSCESS 18 0.0446
18 CYCLIC VOMITING SYNDROME 31 0.0423
19 INJECTION SITE HAEMORRHAGE 3179 0.0398
20 DIABETIC KETOSIS 15 0.0395
21 OBSTRUCTIVE PANCREATITIS 30 0.0392
22 INJECTION SITE MASS 1435 0.0388
23 BLOOD GLUCOSE DECREASED 1854 0.0386
24 HYPERLIPASAEMIA 20 0.0382
25 WRONG PATIENT RECEIVED PRODUCT 110 0.0376
26 INJECTION SITE DISCOMFORT 389 0.0369
27 INJECTION SITE PARAESTHESIA 55 0.0358
28 EARLY SATIETY 69 0.0354
29 DIABETIC RETINOPATHY 119 0.0350
30 EUGLYCAEMIC DIABETIC KETOACIDOSIS 138 0.0334
31 INSULIN RESISTANCE 69 0.0331
32 INJECTION SITE PAIN 10019 0.0326
33 VOMITING PROJECTILE 92 0.0318
34 INCORRECT PRODUCT FORMULATION ADMINISTERED 27 0.0305
35 THYROID MASS 117 0.0305
36 PANCREATITIS 1527 0.0289
37 NECK MASS 81 0.0286
38 GALLBLADDER INJURY 55 0.0282
39 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 517 0.0282
40 DIABETES MELLITUS INADEQUATE CONTROL 495 0.0279
41 BLOOD GLUCOSE FLUCTUATION 304 0.0277
42 GLUCOSE URINE PRESENT 33 0.0259
43 INJURY ASSOCIATED WITH DEVICE 525 0.0258
44 LIPASE INCREASED 195 0.0254
45 PANCREATIC DISORDER 124 0.0251
46 INCORRECT DOSE ADMINISTERED 5663 0.0248
47 INJECTION SITE BRUISING 1971 0.0247
48 INJECTION SITE HYPERSENSITIVITY 77 0.0246
49 PANCREATIC ENZYMES INCREASED 35 0.0239
50 INJECTION SITE HYPOAESTHESIA 34 0.0237
51 FEEDING DISORDER 479 0.0236
52 KETOSIS 25 0.0230
53 ILEUS 277 0.0223
54 INJECTION SITE SCAR 62 0.0217
55 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3843 0.0213
56 AMYLASE INCREASED 78 0.0211
57 WRONG DOSE 51 0.0211
58 BLOOD KETONE BODY INCREASED 16 0.0205
59 BENIGN NEOPLASM OF THYROID GLAND 15 0.0204
60 PANCREATIC CARCINOMA METASTATIC 58 0.0204
61 BODY MASS INDEX INCREASED 27 0.0200
62 INJECTION SITE INDENTATION 43 0.0198
63 INJECTION SITE URTICARIA 480 0.0195
64 INTERCEPTED PRODUCT SELECTION ERROR 25 0.0192
65 INJECTION SITE PRURITUS 1270 0.0189
66 DIABETIC KETOACIDOSIS 455 0.0189
67 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 21 0.0189
68 HUNGER 259 0.0186
69 KETOACIDOSIS 138 0.0184
70 INTERCEPTED PRODUCT DISPENSING ERROR 30 0.0181
71 ADENOCARCINOMA PANCREAS 23 0.0179
72 INJECTION SITE RASH 529 0.0172
73 ACCIDENT AT WORK 36 0.0163
74 FOOD CRAVING 85 0.0161
75 RETINOPATHY 60 0.0161
76 PANCREATIC MASS 17 0.0159
77 PANCREATITIS NECROTISING 36 0.0157
78 DYSPEPSIA 1531 0.0155
79 DIABETIC NEUROPATHY 76 0.0153
80 PRODUCT MONITORING ERROR 22 0.0152
81 GASTRIC DILATATION 25 0.0150
82 FLATULENCE 848 0.0149
83 PANCREATITIS ACUTE 336 0.0149
84 INJECTION SITE VESICLES 90 0.0149
85 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 96 0.0148
86 UNDERDOSE 1079 0.0148
87 URINE KETONE BODY PRESENT 23 0.0146
88 OVERWEIGHT 76 0.0141
89 DECREASED APPETITE 3281 0.0141
90 ILLNESS 1440 0.0140
91 SYSTEMIC INFECTION 23 0.0139
92 DIABETIC COMPLICATION 35 0.0137
93 FOOD AVERSION 23 0.0135
94 DIABETIC FOOT 41 0.0134
95 INJECTION SITE ERYTHEMA 1660 0.0134
96 NAUSEA 10580 0.0134
97 INFREQUENT BOWEL MOVEMENTS 33 0.0132
98 FAT TISSUE INCREASED 19 0.0131
99 PANCREATITIS CHRONIC 30 0.0127
100 VOMITING 5949 0.0126
101 PANCREATIC FAILURE 22 0.0124
102 WEIGHT DECREASED 3438 0.0123
103 ABDOMINAL PAIN UPPER 2512 0.0122
104 GASTROINTESTINAL SOUNDS ABNORMAL 60 0.0121
105 PANCREATIC CYST 23 0.0120
106 INCREASED APPETITE 229 0.0120
107 APPETITE DISORDER 79 0.0119
108 MARASMUS 18 0.0118
109 HYPOGLYCAEMIA 566 0.0117
110 OPTIC ISCHAEMIC NEUROPATHY 45 0.0116
111 PAPILLARY THYROID CANCER 20 0.0115
112 INJECTION SITE IRRITATION 146 0.0115
113 VISUAL IMPAIRMENT 1417 0.0114
114 ABDOMINAL DISTENSION 1182 0.0113
115 HYPOACUSIS 486 0.0113
116 INTESTINAL OBSTRUCTION 424 0.0112
117 PRODUCT DOSE OMISSION 728 0.0111
118 INJECTION SITE INDURATION 144 0.0111
119 CONSTIPATION 2412 0.0110
120 OBSTRUCTIVE SLEEP APNOEA SYNDROME 16 0.0110
121 HICCUPS 89 0.0108
122 INJECTION SITE SWELLING 829 0.0108
123 ABDOMINAL DISCOMFORT 1785 0.0106
124 FLUID INTAKE REDUCED 53 0.0106
125 INJECTION SITE DISCOLOURATION 132 0.0106
126 THYROID NEOPLASM 29 0.0105
127 ABDOMINAL PAIN 2434 0.0105
128 GASTROINTESTINAL PAIN 115 0.0104
129 WRONG PRODUCT ADMINISTERED 67 0.0099
130 BREATH ODOUR 24 0.0098
131 CHOLECYSTITIS 115 0.0096
132 DIARRHOEA 6200 0.0096
133 EATING DISORDER 204 0.0096
134 LICHEN PLANUS 22 0.0095
135 HYPOGLYCAEMIC COMA 27 0.0094
136 LACTIC ACIDOSIS 301 0.0093
137 MALNUTRITION 103 0.0092
138 HYPOPHAGIA 235 0.0092
139 DEHYDRATION 1224 0.0092
140 FOOD POISONING 49 0.0091
141 BOWEL MOVEMENT IRREGULARITY 70 0.0091
142 HYPERPHAGIA 36 0.0090
143 REGURGITATION 31 0.0090
144 GASTROOESOPHAGEAL REFLUX DISEASE 724 0.0090
145 GASTROINTESTINAL DISORDER 800 0.0089
146 GLOMERULAR FILTRATION RATE DECREASED 109 0.0089
147 ABDOMINAL RIGIDITY 24 0.0088
148 NECROTISING FASCIITIS 31 0.0088
149 HYPERCHLORHYDRIA 51 0.0087
150 PANCREATIC CARCINOMA 250 0.0086
151 HYPOGLYCAEMIC UNCONSCIOUSNESS 17 0.0086
152 CHOLELITHIASIS 277 0.0084
153 INJECTION SITE NODULE 92 0.0084
154 TASTE DISORDER 169 0.0083
155 DRUG DOSE OMISSION 1353 0.0082
156 INJECTION SITE INFLAMMATION 40 0.0080
157 HYPERGLYCAEMIA 291 0.0080
158 GANGRENE 48 0.0080
159 PRODUCT DOSE OMISSION ISSUE 2321 0.0079
160 FUNGAL INFECTION 262 0.0079
161 FUNCTIONAL GASTROINTESTINAL DISORDER 27 0.0078
162 FAECES HARD 30 0.0077
163 THYROID CANCER 92 0.0076
164 RETCHING 160 0.0075
165 DIABETIC COMA 21 0.0075
166 PRODUCT STORAGE ERROR 653 0.0075
167 EYE HAEMORRHAGE 98 0.0073
168 SPINAL STENOSIS 30 0.0073
169 GASTROENTERITIS VIRAL 131 0.0072
170 BILIARY COLIC 21 0.0072
171 HYPERPARATHYROIDISM SECONDARY 18 0.0072
172 CATARACT 425 0.0071
173 WEIGHT ABNORMAL 17 0.0071
174 THIRST 126 0.0070
175 ANAL INCONTINENCE 63 0.0070
176 URINE OUTPUT INCREASED 18 0.0069
177 IMMUNE-MEDIATED MYOSITIS 19 0.0069
178 CHOLECYSTITIS ACUTE 39 0.0069
179 POLLAKIURIA 283 0.0068
180 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 482 0.0068
181 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 116 0.0068
182 SLUGGISHNESS 69 0.0068
183 GASTROINTESTINAL INJURY 18 0.0067
184 URINE ODOUR ABNORMAL 39 0.0066
185 VULVOVAGINAL MYCOTIC INFECTION 26 0.0066
186 BILE DUCT STONE 21 0.0066
187 BLOOD TRIGLYCERIDES INCREASED 115 0.0065
188 CHOLECYSTITIS INFECTIVE 18 0.0065
189 NECK INJURY 19 0.0065
190 PAROSMIA 48 0.0064
191 ABDOMINAL MASS 17 0.0063
192 ABSCESS LIMB 27 0.0063
193 ILEUS PARALYTIC 28 0.0063
194 BLOOD LACTIC ACID INCREASED 33 0.0063
195 DECREASED ACTIVITY 67 0.0062
196 INJECTION SITE WARMTH 127 0.0062
197 MASS 86 0.0061
198 SMALL INTESTINAL OBSTRUCTION 75 0.0061
199 COLITIS ISCHAEMIC 41 0.0061
200 BLOOD CHOLESTEROL ABNORMAL 28 0.0061
201 NEPHROGENIC ANAEMIA 28 0.0060
202 WEIGHT INCREASED 1346 0.0060
203 CEREBRAL DISORDER 44 0.0059
204 BACK DISORDER 96 0.0059
205 FEAR OF INJECTION 42 0.0059
206 WRONG PATIENT RECEIVED MEDICATION 16 0.0059
207 FAECALOMA 32 0.0058
208 RENAL FUNCTION TEST ABNORMAL 27 0.0058
209 EPIGASTRIC DISCOMFORT 22 0.0056
210 RENAL DISORDER 262 0.0056
211 SKIN ODOUR ABNORMAL 22 0.0056
212 FEELING ABNORMAL 1338 0.0056
213 THYROID DISORDER 86 0.0056
214 ABNORMAL LOSS OF WEIGHT 38 0.0056
215 ATRIOVENTRICULAR BLOCK 43 0.0056
216 LIMB INJURY 151 0.0056
217 OROPHARYNGEAL DISCOMFORT 50 0.0055
218 BLINDNESS UNILATERAL 78 0.0055
219 MACULAR DEGENERATION 66 0.0055
220 POST-TRAUMATIC STRESS DISORDER 37 0.0055
221 PORTAL HYPERTENSION 17 0.0055
222 DEMENTIA 154 0.0055
223 INJECTION SITE INFECTION 18 0.0055
224 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 93 0.0055
225 ACUTE KIDNEY INJURY 838 0.0055
226 SUSPECTED COVID-19 18 0.0055
227 RETINAL DETACHMENT 50 0.0054
228 HEPATIC STEATOSIS 101 0.0054
229 METABOLIC ACIDOSIS 173 0.0054
230 POLYURIA 43 0.0052
231 RENAL PAIN 55 0.0052
232 BLINDNESS 211 0.0052
233 VULVOVAGINAL PRURITUS 26 0.0051
234 GOITRE 21 0.0051
235 POLYDIPSIA 20 0.0051
236 GASTROINTESTINAL MOTILITY DISORDER 27 0.0050
237 INCORRECT PRODUCT STORAGE 65 0.0049
238 NEPHROLITHIASIS 225 0.0049
239 COVID-19 859 0.0049
240 MEMORY IMPAIRMENT 671 0.0049
241 SEASONAL ALLERGY 69 0.0049
242 GALLBLADDER DISORDER 87 0.0049
243 GASTRITIS 128 0.0049
244 HEPATIC CIRRHOSIS 91 0.0048
245 ROTATOR CUFF SYNDROME 62 0.0048
246 METABOLIC DISORDER 28 0.0048
247 CARDIAC FLUTTER 31 0.0048
248 MALAISE 2100 0.0048
249 FEELING JITTERY 91 0.0048
250 EYE DISORDER 157 0.0048
251 NERVE INJURY 53 0.0048
252 ANKLE FRACTURE 73 0.0047
253 VISION BLURRED 640 0.0047
254 MUSCULOSKELETAL DISCOMFORT 80 0.0046
255 SCRATCH 49 0.0046
256 BLOOD MAGNESIUM DECREASED 40 0.0046
257 FREQUENT BOWEL MOVEMENTS 125 0.0046
258 INJECTION SITE REACTION 317 0.0046
259 PRODUCT ADMINISTRATION INTERRUPTED 36 0.0046
260 MUSCLE ATROPHY 58 0.0046
261 URINE OUTPUT DECREASED 40 0.0046
262 OVERDOSE 981 0.0045
263 INTESTINAL ISCHAEMIA 25 0.0045
264 PRODUCT PRESCRIBING ERROR 108 0.0045
265 MOBILITY DECREASED 325 0.0045
266 CHOLANGITIS 28 0.0045
267 COVID-19 PNEUMONIA 53 0.0045
268 PRODUCT STORAGE ISSUE 17 0.0045
269 GASTROENTERITIS 65 0.0044
270 PRODUCT DISPENSING ERROR 97 0.0044
271 ANAL ABSCESS 24 0.0044
272 NERVE COMPRESSION 41 0.0044
273 PRESYNCOPE 108 0.0044
274 ACCIDENT 53 0.0044
275 B-CELL LYMPHOMA 15 0.0044
276 PHARYNGEAL SWELLING 43 0.0044
277 MENISCUS INJURY 27 0.0044
278 HAEMOGLOBIN INCREASED 20 0.0044
279 BLOOD PRESSURE ABNORMAL 87 0.0044
280 ARTERIAL OCCLUSIVE DISEASE 34 0.0043
281 BLOOD CREATINE INCREASED 19 0.0043
282 NERVOUSNESS 224 0.0043
283 VITREOUS FLOATERS 42 0.0043
284 SLEEP APNOEA SYNDROME 81 0.0042
285 EXPIRED PRODUCT ADMINISTERED 141 0.0042
286 FEBRILE BONE MARROW APLASIA 18 0.0042
287 LIMB DISCOMFORT 131 0.0042
288 MULTIPLE ALLERGIES 33 0.0042
289 TRIGGER FINGER 17 0.0042
290 SENSATION OF FOREIGN BODY 35 0.0041
291 ABNORMAL FAECES 34 0.0041
292 COLD SWEAT 73 0.0041
293 BACK INJURY 45 0.0041
294 HERNIA 80 0.0041
295 PANIC DISORDER 16 0.0041
296 CHRONIC KIDNEY DISEASE 313 0.0041
297 PEMPHIGOID 31 0.0041
298 HYPOVOLAEMIA 24 0.0041
299 NODULE 53 0.0041
300 GLAUCOMA 78 0.0040
301 WEIGHT FLUCTUATION 42 0.0040
302 LOCALISED INFECTION 97 0.0040
303 INTERVERTEBRAL DISC DISORDER 17 0.0040
304 BLOOD POTASSIUM INCREASED 64 0.0039
305 HYPERTRIGLYCERIDAEMIA 23 0.0039
306 HYPERSOMNIA 112 0.0039
307 INJECTION SITE DISCHARGE 21 0.0039
308 INCORRECT DOSAGE ADMINISTERED 19 0.0039
309 DYSGEUSIA 288 0.0039
310 GOUT 69 0.0038
311 HYPERVOLAEMIA 19 0.0038
312 LETHARGY 221 0.0038
313 VAGINAL INFECTION 18 0.0038
314 GASTRIC DISORDER 131 0.0038
315 POST PROCEDURAL INFECTION 31 0.0038
316 THINKING ABNORMAL 71 0.0038
317 ROAD TRAFFIC ACCIDENT 159 0.0038
318 DIABETES MELLITUS 289 0.0038
319 RETINAL HAEMORRHAGE 27 0.0038
320 CORONAVIRUS INFECTION 25 0.0038
321 DIZZINESS 1884 0.0038
322 MACULAR OEDEMA 21 0.0037
323 PRODUCT COMMUNICATION ISSUE 33 0.0037
324 BRAIN NEOPLASM 34 0.0037
325 JOINT INJURY 79 0.0037
326 BLINDNESS TRANSIENT 27 0.0037
327 INJECTION SITE EXTRAVASATION 45 0.0036
328 ABDOMINAL TENDERNESS 18 0.0036
329 LYMPHOEDEMA 25 0.0036
330 SKIN MASS 24 0.0036
331 CARPAL TUNNEL SYNDROME 50 0.0036
332 ASTHENIA 1337 0.0036
333 URINARY TRACT DISORDER 16 0.0035
334 TOE AMPUTATION 18 0.0035
335 IRRITABLE BOWEL SYNDROME 76 0.0035
336 NOCTURIA 43 0.0035
337 DISCOMFORT 216 0.0035
338 CARDIAC DISORDER 331 0.0035
339 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
340 DYSSTASIA 103 0.0035
341 URINE ABNORMALITY 16 0.0035
342 KIDNEY INFECTION 69 0.0035
343 BRAIN FOG 55 0.0035
344 CEREBROVASCULAR ACCIDENT 594 0.0035
345 CONCUSSION 27 0.0035
346 OSTEOMYELITIS 63 0.0035
347 DYSPHONIA 203 0.0035
348 DYSURIA 127 0.0034
349 NECK PAIN 191 0.0034
350 SENSITIVE SKIN 25 0.0034
351 SCIATICA 54 0.0034
352 POLYP 22 0.0034
353 MUSCLE STRAIN 29 0.0033
354 DYSLIPIDAEMIA 17 0.0033
355 FRUSTRATION TOLERANCE DECREASED 27 0.0033
356 HEART RATE INCREASED 331 0.0033
357 DYSGRAPHIA 22 0.0033
358 UPPER LIMB FRACTURE 66 0.0033
359 RASH VESICULAR 16 0.0033
360 BLOOD CALCIUM INCREASED 29 0.0033
361 PERIPHERAL VASCULAR DISORDER 17 0.0033
362 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 667 0.0033
363 VITAMIN D DEFICIENCY 32 0.0033
364 RENAL CYST 26 0.0033
365 BLOOD PRESSURE DIASTOLIC INCREASED 15 0.0032
366 AGEUSIA 81 0.0032
367 MIOSIS 26 0.0032
368 ARTHROPOD BITE 24 0.0032
369 HEART RATE ABNORMAL 18 0.0032
370 BIPOLAR DISORDER 35 0.0032
371 CORONARY ARTERY OCCLUSION 44 0.0032
372 NEOPLASM MALIGNANT 214 0.0032
373 FATIGUE 2489 0.0032
374 ABDOMINAL PAIN LOWER 80 0.0032
375 PNEUMONIA ASPIRATION 79 0.0032
376 TYPE 1 DIABETES MELLITUS 19 0.0032
377 BLOOD PRESSURE INCREASED 481 0.0031
378 OBESITY 50 0.0031
379 LIGAMENT SPRAIN 31 0.0031
380 WEIGHT LOSS POOR 16 0.0031
381 SKIN LACERATION 34 0.0031
382 MOUTH SWELLING 18 0.0031
383 HEPATIC ENCEPHALOPATHY 29 0.0031
384 HEAD DISCOMFORT 55 0.0031
385 NEPHROPATHY 29 0.0031
386 BLOOD PRESSURE DECREASED 206 0.0031
387 TREMOR 514 0.0031
388 MYASTHENIA GRAVIS 25 0.0031
389 DIZZINESS POSTURAL 30 0.0031
390 GAIT INABILITY 103 0.0031
391 DRY MOUTH 250 0.0031
392 SINUS DISORDER 61 0.0031
393 VERTIGO 187 0.0031
394 INTERVERTEBRAL DISC PROTRUSION 67 0.0031
395 CHROMATURIA 69 0.0031
396 INFLUENZA 340 0.0030
397 HAIR GROWTH ABNORMAL 21 0.0030
398 BLOOD POTASSIUM DECREASED 91 0.0030
399 BLADDER DISORDER 30 0.0030
400 HYPERHIDROSIS 388 0.0030
401 RENAL IMPAIRMENT 253 0.0030
402 URINARY TRACT INFECTION 513 0.0030
403 HEMIPLEGIA 25 0.0030
404 DEFAECATION URGENCY 21 0.0030
405 CELLULITIS 151 0.0030
406 ARTHRITIS 235 0.0030
407 NEUROPATHY PERIPHERAL 284 0.0030
408 SCAR 51 0.0030
409 IMMUNE SYSTEM DISORDER 39 0.0030
410 COLON CANCER 44 0.0029
411 INTERVERTEBRAL DISC DEGENERATION 27 0.0029
412 GASTROINTESTINAL INFECTION 26 0.0029
413 DRUG LEVEL INCREASED 48 0.0029
414 APPENDICITIS 27 0.0029
415 DIVERTICULITIS 80 0.0029
416 GAIT DISTURBANCE 552 0.0029
417 FLANK PAIN 27 0.0029
418 DRY THROAT 29 0.0029
419 CARDIAC FAILURE ACUTE 19 0.0028
420 DRUG INEFFECTIVE 3757 0.0028
421 OCULAR DISCOMFORT 32 0.0028
422 BLOOD CHOLESTEROL INCREASED 132 0.0028
423 RENAL FAILURE 376 0.0028
424 RASH PRURITIC 153 0.0028
425 PERIPHERAL SWELLING 434 0.0028
426 PERONEAL NERVE PALSY 16 0.0028
427 DRUG INTOLERANCE 271 0.0028
428 HEADACHE 1758 0.0028
429 FALL 929 0.0028
430 BACK PAIN 648 0.0028
431 SKIN ULCER 72 0.0028
432 VULVOVAGINAL BURNING SENSATION 17 0.0028
433 HERPES VIRUS INFECTION 16 0.0028
434 BLOOD CREATININE INCREASED 181 0.0028
435 AUTOIMMUNE DISORDER 27 0.0028
436 INJECTION SITE HAEMATOMA 40 0.0028
437 HYPOKINESIA 40 0.0028
438 DEAFNESS 72 0.0028
439 ACIDOSIS 21 0.0027
440 CYST 34 0.0027
441 HYPERKALAEMIA 96 0.0027
442 TOOTH FRACTURE 30 0.0027
443 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
444 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24 0.0027
445 MICTURITION URGENCY 31 0.0027
446 BRADYKINESIA 16 0.0027
447 TENDERNESS 28 0.0027
448 MENTAL IMPAIRMENT 65 0.0027
449 GASTROINTESTINAL INFLAMMATION 21 0.0027
450 UPPER-AIRWAY COUGH SYNDROME 22 0.0027
451 HEPATIC CYTOLYSIS 34 0.0027
452 EYE INFECTION 30 0.0027
453 FOOT FRACTURE 50 0.0026
454 ADRENAL INSUFFICIENCY 32 0.0026
455 BLOOD URINE PRESENT 50 0.0026
456 LOSS OF CONSCIOUSNESS 336 0.0026
457 FEELING COLD 73 0.0026
458 MUSCLE SPASMS 480 0.0026
459 TRANSIENT ISCHAEMIC ATTACK 88 0.0026
460 DEPRESSION 592 0.0026
461 LARGE INTESTINE POLYP 18 0.0026
462 HEAD INJURY 82 0.0026
463 ISCHAEMIC STROKE 46 0.0026
464 OLIGURIA 16 0.0026
465 SWELLING 241 0.0026
466 DEPRESSED MOOD 136 0.0026
467 PRE-EXISTING CONDITION IMPROVED 16 0.0026
468 DRUG ADMINISTERED AT INAPPROPRIATE SITE 27 0.0026
469 ASPIRATION 28 0.0026
470 PERIPHERAL COLDNESS 35 0.0025
471 HIATUS HERNIA 33 0.0025
472 ATRIAL FIBRILLATION 248 0.0025
473 PRURITUS GENERALISED 55 0.0025
474 HAND FRACTURE 18 0.0025
475 CHOLECYSTECTOMY 29 0.0025
476 SPINAL DISORDER 24 0.0025
477 EAR DISCOMFORT 26 0.0025
478 DENTAL CARIES 28 0.0025
479 PHOTOPSIA 16 0.0025
480 END STAGE RENAL DISEASE 46 0.0025
481 POSTOPERATIVE WOUND INFECTION 17 0.0025
482 POOR QUALITY SLEEP 54 0.0025
483 PRODUCT DOSE OMISSION IN ERROR 71 0.0025
484 ANXIETY 712 0.0025
485 BALANCE DISORDER 216 0.0025
486 ELECTROLYTE IMBALANCE 29 0.0025
487 BRAIN INJURY 25 0.0025
488 URTICARIA 417 0.0025
489 INSURANCE ISSUE 38 0.0025
490 FLUID RETENTION 126 0.0025
491 DYSPHAGIA 234 0.0025
492 FOOD ALLERGY 19 0.0025
493 LYMPHOMA 38 0.0025
494 DECUBITUS ULCER 20 0.0025
495 AUTOIMMUNE HEPATITIS 17 0.0024
496 MENTAL DISORDER 106 0.0024
497 SHOCK 56 0.0024
498 PULMONARY CONGESTION 32 0.0024
499 HYPERLIPIDAEMIA 29 0.0024
500 GENERALISED OEDEMA 30 0.0024
501 LIVER DISORDER 107 0.0024
502 HYPERSENSITIVITY 447 0.0024
503 THROAT IRRITATION 108 0.0024
504 COLITIS 91 0.0024
505 RASH GENERALISED 62 0.0024
506 LOWER LIMB FRACTURE 46 0.0024
507 NEURALGIA 58 0.0024
508 THERAPEUTIC RESPONSE SHORTENED 79 0.0024
509 TYPE 2 DIABETES MELLITUS 80 0.0024
510 LIVER FUNCTION TEST INCREASED 51 0.0024
511 SINUS CONGESTION 32 0.0024
512 BURNING SENSATION 166 0.0024
513 HAEMATEMESIS 60 0.0024
514 SKIN HAEMORRHAGE 35 0.0024
515 HYPOAESTHESIA 353 0.0024
516 PALPITATIONS 276 0.0024
517 DIARRHOEA HAEMORRHAGIC 22 0.0024
518 FAECES DISCOLOURED 51 0.0023
519 AMNESIA 153 0.0023
520 NASOPHARYNGITIS 433 0.0023
521 MUSCLE TIGHTNESS 38 0.0023
522 PROCEDURAL PAIN 65 0.0023
523 LIP SWELLING 78 0.0023
524 BLOOD TESTOSTERONE DECREASED 16 0.0023
525 ARTERIOSCLEROSIS 22 0.0023
526 FAECES SOFT 17 0.0023
527 BLOOD UREA INCREASED 39 0.0023
528 CARDIAC FAILURE CONGESTIVE 187 0.0023
529 INCORRECT DOSE ADMINISTERED BY DEVICE 61 0.0023
530 PAIN IN EXTREMITY 684 0.0023
531 POISONING DELIBERATE 22 0.0023
532 VIRAL INFECTION 77 0.0023
533 OROPHARYNGEAL PAIN 214 0.0023
534 MUSCULOSKELETAL DISORDER 44 0.0023
535 HAEMORRHAGIC STROKE 18 0.0023
536 MYOCARDIAL INFARCTION 402 0.0023
537 EYE PAIN 130 0.0023
538 DRUG EFFECT LESS THAN EXPECTED 34 0.0023
539 ACUTE CORONARY SYNDROME 19 0.0023
540 CEREBRAL INFARCTION 56 0.0023
541 EXTRASYSTOLES 16 0.0023
542 ACCIDENTAL EXPOSURE TO PRODUCT 235 0.0023
543 SEPSIS 254 0.0023
544 DIPLOPIA 59 0.0023
545 TOOTH ABSCESS 23 0.0023
546 OFF LABEL USE 1975 0.0023
547 WOUND 63 0.0023
548 SYNCOPE 225 0.0022
549 UTERINE CANCER 18 0.0022
550 HEPATOMEGALY 22 0.0022
551 SENSORY LOSS 18 0.0022
552 RECTAL HAEMORRHAGE 96 0.0022
553 URINARY INCONTINENCE 66 0.0022
554 DERMATITIS ALLERGIC 28 0.0022
555 SOMNOLENCE 448 0.0022
556 PHARYNGITIS STREPTOCOCCAL 24 0.0022
557 ALOPECIA 434 0.0022
558 PRURITUS 849 0.0022
559 CARDIAC MURMUR 19 0.0022
560 PYELONEPHRITIS 19 0.0022
561 BLOOD IRON DECREASED 26 0.0022
562 INTERNAL HAEMORRHAGE 25 0.0022
563 RIB FRACTURE 45 0.0022
564 TENDON RUPTURE 27 0.0022
565 SINUSITIS 224 0.0022
566 ACUTE RESPIRATORY FAILURE 42 0.0022
567 INCONTINENCE 23 0.0022
568 INFUSION SITE PAIN 28 0.0022
569 GRIP STRENGTH DECREASED 19 0.0022
570 APHONIA 30 0.0021
571 PARAESTHESIA ORAL 31 0.0021
572 NIGHT SWEATS 69 0.0021
573 CYSTITIS 68 0.0021
574 CHOLESTASIS 41 0.0021
575 FACE OEDEMA 36 0.0021
576 ABSCESS 34 0.0021
577 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60 0.0021
578 SWOLLEN TONGUE 66 0.0021
579 CHOKING 41 0.0021
580 RASH 915 0.0021
581 SKIN HYPERPIGMENTATION 18 0.0021
582 LACRIMATION INCREASED 63 0.0021
583 SLEEP DISORDER 147 0.0021
584 SPEECH DISORDER 109 0.0021
585 HYPERTENSION 440 0.0021
586 ULCER 33 0.0021
587 MIGRAINE 198 0.0021
588 BRONCHITIS 153 0.0021
589 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
590 BURSITIS 25 0.0021
591 UROSEPSIS 19 0.0021
592 HYPOAESTHESIA ORAL 31 0.0021
593 NEUTROPHIL COUNT INCREASED 21 0.0020
594 PRODUCT DISTRIBUTION ISSUE 19 0.0020
595 SPINAL PAIN 24 0.0020
596 DRUG INTERACTION 323 0.0020
597 LYMPHADENOPATHY 72 0.0020
598 THERAPY CHANGE 20 0.0020
599 KNEE OPERATION 20 0.0020
600 BONE DISORDER 37 0.0020
601 CHEST PAIN 375 0.0020
602 DEVICE DIFFICULT TO USE 134 0.0020
603 CONFUSIONAL STATE 327 0.0020
604 CARDIOGENIC SHOCK 29 0.0020
605 EYE SWELLING 75 0.0020
606 CARDIAC FAILURE 161 0.0020
607 ARTHROPATHY 111 0.0020
608 FACIAL PARALYSIS 17 0.0020
609 VITAMIN D DECREASED 17 0.0020
610 COUGH 555 0.0020
611 POST PROCEDURAL COMPLICATION 38 0.0020
612 MUSCLE DISORDER 16 0.0020
613 PAIN 1213 0.0020
614 CONTUSION 190 0.0020
615 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 92 0.0020
616 PHOTOPHOBIA 37 0.0020
617 SPLENOMEGALY 23 0.0020
618 DRUG DISPENSING ERROR 30 0.0020
619 SKIN INFECTION 22 0.0020
620 OSTEOARTHRITIS 83 0.0020
621 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
622 INFLUENZA LIKE ILLNESS 161 0.0020
623 COMA 93 0.0020
624 INITIAL INSOMNIA 20 0.0019
625 SPINAL OPERATION 24 0.0019
626 ORAL DISCOMFORT 27 0.0019
627 MUSCULOSKELETAL CHEST PAIN 30 0.0019
628 PHOTOSENSITIVITY REACTION 32 0.0019
629 MUSCULAR WEAKNESS 219 0.0019
630 HAEMATOCHEZIA 106 0.0019
631 NEOPLASM 22 0.0019
632 IRRITABILITY 115 0.0019
633 SALIVARY HYPERSECRETION 19 0.0019
634 PULMONARY OEDEMA 85 0.0019
635 HAEMOLYTIC ANAEMIA 17 0.0019
636 SARS-COV-2 TEST POSITIVE 25 0.0019
637 FIBROMYALGIA 46 0.0019
638 URINARY RETENTION 63 0.0019
639 ANGINA PECTORIS 54 0.0019
640 DRY EYE 94 0.0019
641 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
642 ANGIOEDEMA 83 0.0019
643 BACTERIAL INFECTION 35 0.0019
644 SNEEZING 42 0.0019
645 BLOOD DISORDER 15 0.0019
646 CARDIAC OPERATION 16 0.0019
647 FEAR 50 0.0019
648 DISTURBANCE IN ATTENTION 100 0.0019
649 SPINAL FRACTURE 37 0.0018
650 FEELING HOT 113 0.0018
651 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
652 ERECTILE DYSFUNCTION 47 0.0018
653 MIDDLE INSOMNIA 34 0.0018
654 SUBDURAL HAEMATOMA 26 0.0018
655 THROMBOSIS 146 0.0018
656 PULMONARY MASS 27 0.0018
657 SWELLING FACE 118 0.0018
658 PANIC ATTACK 66 0.0018
659 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20 0.0018
660 GAMMA-GLUTAMYLTRANSFERASE INCREASED 40 0.0018
661 INSOMNIA 480 0.0018
662 HEART RATE DECREASED 63 0.0018
663 HYPOTHYROIDISM 57 0.0018
664 SKIN DISCOLOURATION 82 0.0018
665 PRODUCT ADMINISTRATION ERROR 36 0.0018
666 HOT FLUSH 134 0.0018
667 EAR INFECTION 47 0.0018
668 ACUTE MYOCARDIAL INFARCTION 52 0.0018
669 TINNITUS 81 0.0018
670 SCAB 20 0.0018
671 EXOSTOSIS 16 0.0018
672 RENAL INJURY 52 0.0017
673 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 91 0.0017
674 DYSPNOEA 986 0.0017
675 INCREASED TENDENCY TO BRUISE 16 0.0017
676 IMPAIRED QUALITY OF LIFE 25 0.0017
677 THROAT TIGHTNESS 47 0.0017
678 IRON DEFICIENCY ANAEMIA 16 0.0017
679 COELIAC DISEASE 17 0.0017
680 NO ADVERSE EVENT 314 0.0017
681 UPPER RESPIRATORY TRACT INFECTION 80 0.0017
682 BODY TEMPERATURE DECREASED 17 0.0017
683 ORTHOSTATIC HYPOTENSION 30 0.0017
684 VISUAL ACUITY REDUCED 57 0.0017
685 QUALITY OF LIFE DECREASED 23 0.0017
686 INABILITY TO AFFORD MEDICATION 17 0.0017
687 IMPAIRED HEALING 56 0.0017
688 SQUAMOUS CELL CARCINOMA 16 0.0017
689 LEUKAEMIA 16 0.0017
690 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
691 SKIN FISSURES 33 0.0017
692 HERPES ZOSTER 97 0.0017
693 MOOD ALTERED 46 0.0017
694 NEEDLE ISSUE 49 0.0017
695 TENDONITIS 26 0.0017
696 SEPTIC SHOCK 73 0.0017
697 SECRETION DISCHARGE 21 0.0017
698 PARALYSIS 24 0.0017
699 HEPATIC ENZYME INCREASED 114 0.0017
700 PARAESTHESIA 263 0.0017
701 MYOCARDIAL ISCHAEMIA 19 0.0017
702 WRIST FRACTURE 20 0.0017
703 GENERAL PHYSICAL HEALTH DETERIORATION 193 0.0017
704 DERMATITIS CONTACT 19 0.0017
705 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
706 HYPOMAGNESAEMIA 23 0.0017
707 NASAL CONGESTION 97 0.0016
708 CHILLS 193 0.0016
709 EAR PAIN 32 0.0016
710 WOUND INFECTION 18 0.0016
711 OEDEMA 89 0.0016
712 BLOOD PRESSURE SYSTOLIC INCREASED 32 0.0016
713 RHINORRHOEA 106 0.0016
714 BLOOD TEST ABNORMAL 23 0.0016
715 COLITIS ULCERATIVE 73 0.0016
716 GASTRIC ULCER 31 0.0016
717 VASCULITIS 19 0.0016
718 ARTHRALGIA 678 0.0016
719 PRODUCT ODOUR ABNORMAL 17 0.0016
720 CORONARY ARTERY DISEASE 49 0.0016
721 MYALGIA 275 0.0016
722 CARDIOVASCULAR DISORDER 41 0.0016
723 INTENTIONAL DOSE OMISSION 46 0.0016
724 STAPHYLOCOCCAL INFECTION 53 0.0016
725 MUSCLE TWITCHING 37 0.0016
726 ASTHMA 181 0.0016
727 FRACTURE 30 0.0016
728 ANAPHYLACTIC REACTION 87 0.0016
729 CRYING 57 0.0016
730 MUSCULOSKELETAL PAIN 82 0.0016
731 SKIN REACTION 22 0.0016
732 SKIN DISORDER 52 0.0016
733 DEVICE DEFECTIVE 27 0.0016
734 TACHYCARDIA 138 0.0016
735 PSORIATIC ARTHROPATHY 63 0.0016
736 HEPATOCELLULAR INJURY 22 0.0016
737 INFLAMMATION 80 0.0015
738 HEART RATE IRREGULAR 35 0.0015
739 HAEMORRHOIDS 30 0.0015
740 FOOT DEFORMITY 17 0.0015
741 DEVICE MECHANICAL ISSUE 21 0.0015
742 ARRHYTHMIA 72 0.0015
743 JOINT DISLOCATION 16 0.0015
744 BLOOD CALCIUM DECREASED 17 0.0015
745 HEREDITARY ANGIOEDEMA 16 0.0015
746 HYPOTENSION 299 0.0015
747 EYE PRURITUS 50 0.0015
748 DEVICE USE ISSUE 26 0.0015
749 BLOOD SODIUM DECREASED 28 0.0015
750 EOSINOPHILIA 26 0.0015
751 THERAPY INTERRUPTED 106 0.0015
752 BASAL CELL CARCINOMA 23 0.0015
753 ORAL PAIN 33 0.0015
754 OESOPHAGITIS 16 0.0015
755 DYSPNOEA EXERTIONAL 55 0.0015
756 BLOOD PRESSURE FLUCTUATION 35 0.0015
757 HYPOKALAEMIA 67 0.0015
758 CHEST DISCOMFORT 148 0.0014
759 ECZEMA 75 0.0014
760 JOINT SWELLING 173 0.0014
761 HIP FRACTURE 46 0.0014
762 PERICARDIAL EFFUSION 33 0.0014
763 LIVER INJURY 35 0.0014
764 METASTASES TO LIVER 25 0.0014
765 HEPATITIS 36 0.0014
766 PRODUCTIVE COUGH 67 0.0014
767 MOVEMENT DISORDER 45 0.0014
768 TOOTH DISORDER 31 0.0014
769 COGNITIVE DISORDER 65 0.0014
770 BLISTER 78 0.0014
771 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
772 DEVICE LEAKAGE 60 0.0014
773 RASH PAPULAR 31 0.0014
774 HYPERCALCAEMIA 17 0.0014
775 HEPATIC CANCER 33 0.0014
776 APATHY 20 0.0014
777 OXYGEN SATURATION DECREASED 77 0.0014
778 INFECTION 197 0.0014
779 APHASIA 41 0.0014
780 EJECTION FRACTION DECREASED 21 0.0013
781 PRESCRIBED OVERDOSE 26 0.0013
782 PNEUMONIA 435 0.0013
783 INTENTIONAL PRODUCT MISUSE 117 0.0013
784 PRODUCT USE COMPLAINT 21 0.0013
785 INTRAOCULAR PRESSURE INCREASED 17 0.0013
786 KNEE ARTHROPLASTY 28 0.0013
787 MUSCULOSKELETAL STIFFNESS 115 0.0013
788 DRUG-INDUCED LIVER INJURY 41 0.0013
789 OCULAR HYPERAEMIA 62 0.0013
790 LUNG DISORDER 64 0.0013
791 C-REACTIVE PROTEIN INCREASED 47 0.0013
792 ORAL CANDIDIASIS 17 0.0013
793 TOOTH INFECTION 17 0.0013
794 MOOD SWINGS 41 0.0013
795 RESTLESSNESS 47 0.0013
796 PRODUCT AVAILABILITY ISSUE 29 0.0013
797 EXPOSURE VIA SKIN CONTACT 33 0.0013
798 ANGER 43 0.0013
799 TOOTHACHE 23 0.0013
800 SINUS TACHYCARDIA 18 0.0013
801 JAUNDICE 34 0.0013
802 SURGERY 74 0.0013
803 RASH MACULAR 44 0.0013
804 JOINT STIFFNESS 33 0.0013
805 CEREBRAL HAEMORRHAGE 45 0.0013
806 RASH ERYTHEMATOUS 60 0.0013
807 SKIN CANCER 27 0.0013
808 PALLOR 34 0.0012
809 DRUG PRESCRIBING ERROR 24 0.0012
810 PSORIASIS 163 0.0012
811 DEVICE ISSUE 111 0.0012
812 RESPIRATORY DISORDER 37 0.0012
813 BREAST CANCER 115 0.0012
814 THERAPY CESSATION 63 0.0012
815 EYE IRRITATION 70 0.0012
816 RASH MACULO-PAPULAR 27 0.0012
817 DYSKINESIA 49 0.0012
818 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
819 INCORRECT ROUTE OF DRUG ADMINISTRATION 43 0.0012
820 TACHYPNOEA 16 0.0012
821 DRY SKIN 157 0.0012
822 GINGIVAL BLEEDING 16 0.0012
823 THERAPEUTIC RESPONSE DECREASED 71 0.0012
824 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
825 HAEMORRHAGE 121 0.0012
826 GASTRIC CANCER 29 0.0011
827 ANHEDONIA 30 0.0011
828 MELAENA 25 0.0011
829 RHABDOMYOLYSIS 47 0.0011
830 CANDIDA INFECTION 19 0.0011
831 TRANSAMINASES INCREASED 25 0.0011
832 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 54 0.0011
833 DRUG DOSE OMISSION BY DEVICE 88 0.0011
834 NERVOUS SYSTEM DISORDER 35 0.0011
835 SEIZURE 129 0.0011
836 DISORIENTATION 44 0.0011
837 HAEMATURIA 38 0.0011
838 FEMUR FRACTURE 34 0.0011
839 ACUTE HEPATIC FAILURE 15 0.0011
840 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 78 0.0011
841 PRODUCT PHYSICAL ISSUE 22 0.0011
842 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
843 EMOTIONAL DISTRESS 131 0.0011
844 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
845 UPPER GASTROINTESTINAL HAEMORRHAGE 18 0.0011
846 EPISTAXIS 80 0.0011
847 DYSARTHRIA 40 0.0011
848 PAIN IN JAW 30 0.0011
849 ALANINE AMINOTRANSFERASE INCREASED 65 0.0011
850 ASPARTATE AMINOTRANSFERASE INCREASED 56 0.0011
851 LUNG NEOPLASM MALIGNANT 43 0.0010
852 PHARYNGEAL OEDEMA 16 0.0010
853 RHEUMATOID ARTHRITIS 118 0.0010
854 SUICIDAL IDEATION 95 0.0010
855 ANOSMIA 15 0.0010
856 OEDEMA PERIPHERAL 125 0.0010
857 MULTIPLE SCLEROSIS 49 0.0010
858 BONE PAIN 60 0.0010
859 SKIN LESION 28 0.0010
860 ASCITES 30 0.0010
861 ERYTHEMA 209 0.0010
862 VAGINAL HAEMORRHAGE 44 0.0010
863 HYPONATRAEMIA 57 0.0010
864 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
865 ILL-DEFINED DISORDER 61 0.0010
866 HYPOCALCAEMIA 19 0.0010
867 HAEMATOMA 26 0.0010
868 PROTEINURIA 19 0.0010
869 RESPIRATORY TRACT INFECTION 26 0.0010
870 LIVER FUNCTION TEST ABNORMAL 29 0.0010
871 LEUKOCYTOSIS 18 0.0010
872 HAEMOGLOBIN DECREASED 102 0.0010
873 HEPATIC FUNCTION ABNORMAL 37 0.0010
874 RESTLESS LEGS SYNDROME 18 0.0010
875 ECONOMIC PROBLEM 15 0.0010
876 PYREXIA 341 0.0010
877 INJURY 69 0.0010
878 PRODUCT PREPARATION ERROR 20 0.0010
879 ORAL HERPES 19 0.0010
880 DELUSION 15 0.0010
881 FLUSHING 98 0.0010
882 PULMONARY EMBOLISM 91 0.0010
883 HALLUCINATION 72 0.0010
884 TREATMENT NONCOMPLIANCE 52 0.0009
885 DEVICE USE ERROR 33 0.0009
886 ANAEMIA 181 0.0009
887 HEMIPARESIS 16 0.0009
888 CARDIO-RESPIRATORY ARREST 39 0.0009
889 CONDITION AGGRAVATED 283 0.0009
890 BLOOD BILIRUBIN INCREASED 25 0.0009
891 INTENTIONAL PRODUCT USE ISSUE 81 0.0009
892 SKIN EXFOLIATION 78 0.0009
893 DEVICE DELIVERY SYSTEM ISSUE 25 0.0009
894 PULMONARY HYPERTENSION 19 0.0009
895 CARDIAC ARREST 75 0.0009
896 HAEMATOCRIT DECREASED 18 0.0009
897 DERMATITIS 19 0.0009
898 LYMPHOCYTE COUNT DECREASED 16 0.0009
899 DEATH 777 0.0009
900 MOUTH ULCERATION 19 0.0009
901 PAIN OF SKIN 24 0.0009
902 PNEUMONITIS 24 0.0009
903 LABORATORY TEST ABNORMAL 26 0.0009
904 HYPOXIA 31 0.0009
905 MATERNAL EXPOSURE DURING PREGNANCY 78 0.0009
906 DERMATITIS ATOPIC 46 0.0009
907 AGITATION 64 0.0009
908 ANAPHYLACTIC SHOCK 22 0.0009
909 OSTEOPOROSIS 35 0.0009
910 EMOTIONAL DISORDER 26 0.0008
911 SUICIDE ATTEMPT 51 0.0008
912 PRODUCT USE ISSUE 158 0.0008
913 NIGHTMARE 29 0.0008
914 ABNORMAL DREAMS 23 0.0008
915 ABNORMAL BEHAVIOUR 33 0.0008
916 TOOTH LOSS 17 0.0008
917 DEVICE MALFUNCTION 57 0.0008
918 BRADYCARDIA 43 0.0008
919 CONJUNCTIVITIS 15 0.0008
920 INTERSTITIAL LUNG DISEASE 39 0.0008
921 HALLUCINATION, VISUAL 17 0.0008
922 FULL BLOOD COUNT DECREASED 16 0.0008
923 UNEVALUABLE EVENT 60 0.0008
924 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
925 RED BLOOD CELL COUNT DECREASED 22 0.0008
926 PLATELET COUNT DECREASED 82 0.0008
927 GLOSSODYNIA 17 0.0008
928 STOMATITIS 46 0.0008
929 IMPAIRED WORK ABILITY 16 0.0007
930 WHEEZING 44 0.0007
931 PRODUCT PRESCRIBING ISSUE 16 0.0007
932 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
933 APPLICATION SITE PAIN 16 0.0007
934 SKIN IRRITATION 33 0.0007
935 PLASMA CELL MYELOMA 28 0.0007
936 RESPIRATORY FAILURE 52 0.0007
937 ENCEPHALOPATHY 17 0.0007
938 RESPIRATORY DISTRESS 19 0.0007
939 PRODUCT USE IN UNAPPROVED INDICATION 168 0.0007
940 DEEP VEIN THROMBOSIS 44 0.0007
941 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
942 TARDIVE DYSKINESIA 19 0.0007
943 DISEASE RECURRENCE 32 0.0007
944 UNRESPONSIVE TO STIMULI 17 0.0007
945 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
946 EPILEPSY 20 0.0007
947 PLEURAL EFFUSION 39 0.0006
948 BONE DENSITY DECREASED 20 0.0006
949 RENAL CANCER 30 0.0006
950 DRUG RESISTANCE 16 0.0006
951 HOSPITALISATION 93 0.0006
952 DELIRIUM 21 0.0006
953 THERAPY NON-RESPONDER 27 0.0006
954 WHITE BLOOD CELL COUNT DECREASED 65 0.0006
955 PROSTATE CANCER 47 0.0006
956 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
957 MEDICATION ERROR 32 0.0006
958 PSYCHOTIC DISORDER 17 0.0006
959 HAEMOPTYSIS 16 0.0006
960 PANCYTOPENIA 32 0.0006
961 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 19 0.0006
962 BLADDER CANCER 33 0.0006
963 AGGRESSION 28 0.0006
964 ADVERSE DRUG REACTION 50 0.0006
965 ACNE 41 0.0005
966 ADVERSE EVENT 49 0.0005
967 TREATMENT FAILURE 44 0.0005
968 HEPATIC FAILURE 16 0.0005
969 MULTIPLE SCLEROSIS RELAPSE 36 0.0005
970 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
971 THROMBOCYTOPENIA 58 0.0005
972 NEOPLASM PROGRESSION 18 0.0005
973 SKIN BURNING SENSATION 37 0.0005
974 INTENTIONAL OVERDOSE 33 0.0005
975 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
976 DRUG EFFECT DECREASED 26 0.0005
977 INFUSION RELATED REACTION 31 0.0005
978 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
979 PRODUCT QUALITY ISSUE 59 0.0004
980 PRODUCT SUBSTITUTION ISSUE 25 0.0004
981 WITHDRAWAL SYNDROME 18 0.0004
982 NEUTROPENIA 57 0.0004
983 FEBRILE NEUTROPENIA 22 0.0003
984 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
985 TOXICITY TO VARIOUS AGENTS 48 0.0003
986 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
987 EXPOSURE DURING PREGNANCY 17 0.0003
988 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
989 DISEASE PROGRESSION 30 0.0003
990 COMPLETED SUICIDE 16 0.0002
991 DRUG WITHDRAWAL SYNDROME 15 0.0002
992 DRUG DEPENDENCE 17 0.0001